Maddalena Marinoni

Dr. Maddalena Marinoni

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 October 2019 in Nutrients
Verified
Journal Article
Open access
PDF file
SSsilvia salvatore
silvia salvatore
EBElisabetta Bertoni
Elisabetta Bertoni
FBFederica Bogni
Federica Bogni
VBValentina Bonaita
Valentina Bonaita
CAChiara Armano
Chiara Armano
MAMassimo Agosti
Massimo Agosti
The diagnosis of cow’s milk allergy (CMA) is particularly challenging in infants, especially with non-Immunoglobulin E (IgE)-mediated manifestations, and inaccurate diagnosis may lead to unnecessary dietary restrictions. The aim of this study was to assess the accuracy of the cow’s milk-related symptom score (CoMiSSTM) in response to a cow’s milk-free diet (CMFD). We prospectively recruited 47 infants (median age three months) who had been placed on a CMFD due to persisting unexplained gastrointestinal symptoms. We compared data with 94 healthy controls (median age three months). The CoMiSSTM score was completed at recruitment and while on the exclusion diet. In 19/47 (40%) cases a response to the diet occurred. At recruitment CoMiSSTM was significantly higher in cases compared to controls (median score 8 vs. 3; p-value: <0.05), 9 cases had a score ≥12 and 8/9 normalized on CMFD. An oral milk challenge was performed in all 19 responders and six of these had a positive reaction to cow’s milk (CM). In eight infants IgE allergy tests were positive. The receiver operation characteristic (ROC) curve identified a CoMISSTM score of 9 to be the best cut-off value (84% sensitivity, 85% specificity, 80% positive (PPV) and 88% negative predictive value (NPV)) for the response to CMFD. We found CoMiSSTM to be a useful tool to help identify infants with persisting gastrointestinal symptoms and suspected CMA that would benefit from CMFD.

29 May 2022 in European Journal of Immunology
Verified
Journal Article
Open access
GMGiulia Milardi
Giulia Milardi
BLBiagio Di Lorenzo
Biagio Di Lorenzo
JGJolanda Gerosa
Jolanda Gerosa
FBFederica Barzaghi
Federica Barzaghi
GMGigliola Di Matteo
Gigliola Di Matteo
GFGeorgia Fousteri
Georgia Fousteri
Common variable immunodeficiency (CVID) is the most frequent primary antibody deficiency whereby follicular helper T (Tfh) cells fail to establish productive responses with B cells in germinal centers. Here, we analyzed the frequency, phenotype, transcriptome, and function of circulating Tfh (cTfh) cells in CVID patients displaying autoimmunity as an additional phenotype. A group of patients showed a high frequency of cTfh1 cells and a prominent expression of PD‐1 and ICOS as well as a cTfh mRNA signature consistent with highly activated, but exhausted, senescent, and apoptotic cells. Plasmatic CXCL13 levels were elevated in this group and positively correlated with cTfh1 cell frequency and PD‐1 levels. Monoallelic variants in RTEL1, a telomere length‐ and DNA repair‐related gene, were identified in four patients belonging to this group. Their blood lymphocytes showed shortened telomeres, while their cTfh were more prone to apoptosis. These data point toward a novel pathogenetic mechanism in CVID, whereby alterations in DNA repair and telomere elongation might predispose to antibody deficiency. A Th1, highly activated but exhausted and apoptotic cTfh phenotype was associated with this form of CVID.

28 January 2020 in Journal of Clinical Immunology
Verified
Journal Article
Closed access
PDF file
GOGiorgio Ottaviano
Giorgio Ottaviano
JGJolanda Gerosa
Jolanda Gerosa
MSMicaela Santini
Micaela Santini
PLPasqualina De Leo
Pasqualina De Leo
AVAndrea Vecchione
Andrea Vecchione
GFGeorgia Fousteri
Georgia Fousteri

30 April 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
AGAngela Guarina
Angela Guarina
ABAngelica Barone
Angelica Barone
ATassunta tornesello
assunta tornesello
MMMaddalena Marinoni
Maddalena Marinoni
GLGiuseppe Lassandro
Giuseppe Lassandro
PFPiero Farruggia
Piero Farruggia
Background: The association between inflammatory bowel disease (IBD) and immune thrombocytopenia (ITP) is still uncertain. In this multicenter retrospective study, the coexistence of both diseases was investigated in children diagnosed from 1 January 2000 to 31 December 2019. Methods: Clinical characteristics of both IBD and ITP, onset of disorders, and patient’s response to treatment were collected through a structured form sent to 55 Italian pediatric referring centers for hematological disorders. Result: Centers responded to the survey and reported the coexistence of IBD and ITP in 14 children. The first diagnosis was ITP in 57.1% and IBD in 35.7% of patients: it was simultaneous in 7.1%. IBD was classified as ulcerative colitis (57.1%), Crohn disease (35.7%), and unclassified (7.1%). No therapy for IBD other than steroids had any effect on ITP course. Colectomy resulted in recovery from ITP in 1 of the 2 patients surgically treated. ITP was always mild but turned to be chronic in half of patients. Conclusions: In all patients, ITP was mild without any evident impact on IBD severity, but the incidence of chronic ITP seems to be higher than what is usually observed in the pediatric age group. Colectomy had unpredictable effects on ITP.

1 December 2020 in JAMA Pediatrics
Verified
Journal Article
Open access
PDF file
SSsilvia salvatore
silvia salvatore
MMMaddalena Marinoni
Maddalena Marinoni
MAMassimo Agosti
Massimo Agosti
To the Editor We read with great interest “Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and Adolescents: A Systematic Revi

18 May 2021 in Turkish Journal of Hematology
Verified
Journal Article
Open access
AGAngela Guarina
Angela Guarina
MMMaddalena Marinoni
Maddalena Marinoni
GLGiuseppe Lassandro
Giuseppe Lassandro
PSPaola Saracco
Paola Saracco
SPSilverio Perrotta
Silverio Perrotta
PFPiero Farruggia
Piero Farruggia
Objective: The association between celiac disease (CD) and immune thrombocytopenia (ITP) is still uncertain. The aim of this study was to characterize the coexistence of these two diseases in Italian children. Materials and Methods: This is a retrospective multicenter study investigating the occurrence of CD in 28 children with ITP diagnosed from January 1, 2000, to December 31, 2019. Results: The first diagnosis was ITP in 57.1% and CD in 32.1 % of patients. In 3 patients (10.7%), the two diagnoses were simultaneous. All the potential and silent cases of CD in our cohort were diagnosed in the groups of "ITP first" and "simultaneous diagnosis". In all children ITP was mild, and in 2 out of 8 not recovered from ITP at the time of CD diagnosis a normalization of platelet counts (>100,000/mu L) occurred 3 and 5 months after starting a gluten-free diet, respectively. Conclusion: We think that screening for CD should be considered in children with ITP regardless of the presence of gastrointestinal symptoms. Furthermore, some patients may recover from ITP after starting a gluten-free diet.